LipiFlow® Thermal Pulsation System Effectively Treats Meibomian Gland Dysfunction
April 4, 2012
The results of a randomized, controlled clinical study involving 139 patients with Meibomian Gland Dysfunction (MGD), to be published in the April 2012 issue of Cornea, compared results for treatment of MGD with the LipiFlow® Thermal Pulsation System from TearScience versus warm compress.
Treatment with LipiFlow® provided sustained improvement, on average, in both signs and symptoms.
Further, the study demonstrated the clinical utility, safety and effectiveness of LipiFlow® in adult patients with MGD and dry eye symptoms.
Click here for further details on the study.
LipiFlow®, which applies heat and gentle pressure to a patient’s eyelid, is designed to liquefy and evacuate obstructions in Meibomian glands during a 12-minute in-office procedure. The goal of unblocking the glands is to allow them to resume their natural production of lipids required for a healthy tear film. LipiFlow®’s second generation product allows physicians to treat two eyes simultaneously.
You might also enjoy...
- LipiFlow Treatment for Meibomian Gland Dysfunction Approved by FDA
- Probing to Treat Meibomian Gland Dysfunction
- What Are Treatment Options for Loss of Zeis, Moll and Meibomian Glands Due to Stevens-Johnson Syndrome/TEN?
- Glaucoma Patients Will be Able to Use New Tonometer at Home to Measure Eye Pressure Through Eyelid
- IOPtima Reports Successful Long-Term Results in the Use of its Laser System for Treatment of Glaucoma
Comments
Jump down to form below to submit your own comments
